StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > U of T MD Anderson Cancer Center... PHI, not ColonSentry

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Apr 01, 2021 11:27pm

155 Views

Post# 32928720

RE:U of T MD Anderson Cancer Center... PHI, not ColonSentry

Still pretty cool

Nailbiter1 wrote: The University of Texas MD Anderson Cancer Center is honored to rank No. 1 in cancer care in the U.S. News & World Report's 2020-21 “Best Hospitals” survey. The institution has been named one of the nation's top two cancer hospitals since the survey's inception in 1990.

GeneNews' Innovative Diagnostic Laboratory J-V To Provide PHI Testing Services To MD Anderson Cancer Center
Published: Sep 04, 2015

https://www.biospace.com/article/releases/genenews-b-innovative-diagnostic-laboratory-j-v-b-to-provide-phi-testing-services-to-md-anderson-cancer-center-/